“GLP-1 agonists are relatively new and high-profile classes of medicines used to treat type 2 diabetes mellitus but more recently, they have gained …
By Daniel Wege
Consultor HAZOP Especializado em IA | 20+ Anos Transformando Riscos em Resultados | Experiência Global: PETROBRAS, SAIPEM e WALMART
